EMD Crop BioScience
Francis Leier, Business Development Manager, EMD Crop BioScience
Francis Leier, Business Development Manager, EMD Crop BioScience
Francis Leier discusses how EMD’s parent company, Merck, recently sold its crop bioscience business (which includes EMD Crop BioScience) in the U.S.A, Canada and South America to Novozymes.
Francis Leier, Business Development Manager, EMD Crop BioScience
Francis Leier explains why Novozymes is a good fit for EMD.
Francis Leier, Business Development Manager, EMD Crop BioScience
Francis Leier tells Seed World what’s in the pipeline for the next few years.
Francis Leier, Business Development Manager, EMD Crop BioScience
Francis Leier explains the science behind EMD’s patented LCO Promoter technology.
Francis Leier, Business Development Manager, EMD Crop BioScience
Francis Leier discusses what direction he thinks the seed enhancement sector will take in the next 5-10 years.
Francis Leier, Business Development Manager, EMD Crop BioScience
Francis Leier explains how seed enhancements can be improved.
Francis Leier, Business Development Manager, EMD Crop BioScience
Francis Leier discusses the role seed enhancements play in helping to achieve food security.
Francis Leier, Business Development Manager, EMD Crop BioScience
Francis Leier discusses the distinction between a seed treatment and a seed enhancement.
